TQT Studies are one of the most important elements of new drug development. These studies are significant and their outcome has major impact on a drug development program. However, these studies are relatively novel and there may still be a level of doubt when assigning the studies

Some of the reason for this may be:

• Best practice for the conduct of TQT studies is still emerging

• Overall, these studies are generally expensive to conduct

• ECG central core laboratories do not have any incentive to develop efficient methods for assessing NCEs

Tackling concept, design, conduct, analysis and interpretation

A positive indication attained from TQT studies does not mean that new chemical entities will cause TDP with connected threat of unforeseen death, though…

A positive signal has however a major impact on the development of a NCE. For this reason, the early conduct of a TQT study is desirable but the cost may be prohibitive given the high attrition rate in early phase studies.

Richmond Pharmacology is Europe’s leading Clinical Research Organisation specialising in Thorough QT/QTc, Clinical Data Management and Pharmaceutical Research. With a Core ECG Lab and experienced medical professionals Richmond Pharmacology conducts Clinical Trials for the purpose of new NCE

Key elements

TQT studies could be conducted at a much earlier stage of development and in any case more
frequently, if a there is a significant reduction in cost, based on 3 key elements can be
achieved.

These are

• Design 

• Conduct 

• Analysis

 

 

Related posts:

  1. Logo Development: Creating Successful Business Logo As any victorious business owner knows, the key to...
  2. The Benefits of Outsourcing Difficult Web Development Projects The web development world has tremendously expanded over the...
  3. Checklist To Help You With Design And Development Of Your Site Here is a checklist to help with your website...
  4. Software Development UK Businesses look to software development as a means to...
  5. Clinical Research - Light at the End of a Tough Year It was a challenging year for the clinical research...

Like this post? Subscribe to my RSS feed and get loads more!